Triteq Attends Biomedical Engineering Conference
Andrew Larkins, the operations director of Triteq, last month joined discussions as a speaker at the first Middle East Conference on Biomedical Engineering (MECBME). The event was hosted by Sultan Bin Mohammad Al Qassimi, ruler of Sharjah and president of the American University of Sharjah, which provided a forum for engineers, scientists and researchers to meet and share biomedical engineering knowledge.
Mr Larkins was able to advise on the process of commercialising academic research, including intellectual property rights, skilled development resources, regulatory requirements, route to market and funding. Discussions brought up some key issues, unique to the Middle East, such as an absence of technology transfer. Researchers are keen to establish a process where the public can benefit from advances in technology, but there is currently no support in place for this, as with western countries.
Other key issues to be addressed were patenting and protecting intellectual property to reduce the risk of exploitation, as well as an understanding of regulatory requirements. Discussions on the subject of 'route to market' for medical applications suggested that there was an opportunity for researchers to develop technology compatible with hand-held consumer devices such as Apple's Iphone, so they could enjoy quicker development times. Triteq will be maintaining contact with the region, to help encourage project collaboration between Europe and Middle East.
Mr Larkins was able to advise on the process of commercialising academic research, including intellectual property rights, skilled development resources, regulatory requirements, route to market and funding. Discussions brought up some key issues, unique to the Middle East, such as an absence of technology transfer. Researchers are keen to establish a process where the public can benefit from advances in technology, but there is currently no support in place for this, as with western countries.
Other key issues to be addressed were patenting and protecting intellectual property to reduce the risk of exploitation, as well as an understanding of regulatory requirements. Discussions on the subject of 'route to market' for medical applications suggested that there was an opportunity for researchers to develop technology compatible with hand-held consumer devices such as Apple's Iphone, so they could enjoy quicker development times. Triteq will be maintaining contact with the region, to help encourage project collaboration between Europe and Middle East.
Comments